SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma

Blood Cancer J. 2021 Dec 14;11(12):201. doi: 10.1038/s41408-021-00597-y.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • BNT162 Vaccine / therapeutic use*
  • COVID-19 / epidemiology*
  • COVID-19 / immunology*
  • COVID-19 / prevention & control
  • Female
  • Humans
  • Immunocompromised Host*
  • Male
  • Middle Aged
  • Multiple Myeloma / immunology
  • Multiple Myeloma / virology*
  • SARS-CoV-2

Substances

  • BNT162 Vaccine